Connect
MJA
MJA

When ‘Liver Enzymes’ Are Not Hepatic: Late-Onset Pompe Disease

Shauna Madigan, Georgina England, Wayne Rankin
Correspondence: wayne.rankin@sa.gov.au
Med J Aust 2026; 224 (6) || doi: 10.5694/mja2.70228
Published online: 11 June 2026

Abstract

Elevated liver function tests are commonly attributed to hepatic disease but may reflect extrahepatic pathology. We describe the case of an 18-year-old athletic woman with a 2-year history of elevated aspartate aminotransferase (AST), alanine aminotransferase (ALT) and creatine kinase (CK) levels, initially investigated extensively for hepatic causes. Despite normal liver imaging and biopsy, ongoing abnormalities prompted metabolic evaluation, leading to the diagnosis of late-onset Pompe disease. This case highlights the diagnostic challenges of rare metabolic myopathies, the importance of recognising muscle-derived aminotransferase elevation and the need for broad diagnostic consideration when standard investigations are unrevealing.

  • Shauna Madigan, Georgina England, Wayne Rankin



Correspondence: wayne.rankin@sa.gov.au

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.